期刊文献+

非典型性抗精神病药物相关的相互作用 被引量:5

Pharmacodynamic interactions of atypical antipsychotics
下载PDF
导出
摘要 该文通过分析非典型抗精神病药物(SGA)类药物相关的相互作用的研究论文及综述,探讨了SGA常见的药物联用的药效学相互作用。研究表明非典型抗精神病药物与其他药物的相互作用主要与细胞色素P450酶有关,也与UGT酶系及P-糖蛋白系统有关。医生在使用SGA类药物时须了解它潜在的PK/PD相互作用,避免和减少不良反应的发生。 In this paper, we analyzed the interaction of atypical antipsychotic drugs(SGA), and explored the pharmacodynamic interaction of common drug combination in SGA. According to the study of atypical antipsychotic drugs and other drug interactions are mainly related to the cytochrome P450 enzyme, and also with the UGT enzyme system and P- glycoprotein system. Physicians need to understand the potential of PK/PD to avoid and reduce the occurrence of adverse reactions when using SGA.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第34期86-89,共4页 China Journal of Modern Medicine
关键词 非典型抗精神病药物 P450酶 相互作用 atypical antipsychotics cytochrome P450 enzymes interactions
  • 相关文献

参考文献29

  • 1WILLIAM KLUGH KENNEDY,MICHAEL W.JANN,ERIC C,et al.Clinically significant drug interactions with atypical antipsychotics[J].CNS Drugs,2013,27(12):1021-1048. 被引量:1
  • 2LIANA URICHUK,TREVOR I.PRIOR,SERDAR DURSUN,et al.Metabolism of atypical antipsychotics:involvement of cytochrome P450 enzymes and relevance for drug-drug interactions[J].Current Drug Metabolism,2008,9(5):410-418. 被引量:1
  • 3陈颖,吴晓燕,瞿发林.非典型抗精神病药物的代谢及其引起的药物相互作用[J].实用药物与临床,2010,13(5):374-376. 被引量:8
  • 4MARKOWITZ JS,DEVANE CL,LISTON HL,et al.The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers[J].Clin Pharmacol Ther,2002,71(1):30-38. 被引量:1
  • 5唐密密,江沛,李焕德.非典型抗精神病药的体内代谢与药物相互作用[J].中南药学,2012,10(8):608-613. 被引量:10
  • 6MOONS T,DE ROO M,CLEES S,et al.Relationship between P-glycoprotein and second generation antipsychotics[J].Pharmacogenomics,2011,12(8):1193-1211. 被引量:1
  • 7张石宁,姚辉,李继民,林红,陆水平,尚晓芳,王筱兰,孙静,谭俊华,韩钢.利培酮与氟西汀合并治疗精神分裂症的相互作用[J].中国临床药理学杂志,2009,25(1):11-13. 被引量:7
  • 8SPINA E,AVENOSO A,SCORDO MG,et al.Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia:a clinically relevent pharmacokinetic drug interaction[J].Clin Psychopharmacol,2002,22(4):419-423. 被引量:1
  • 9MARINO J,CABALLERO J.Hoperidone for the treatment of schizophrenia[J].Ann Pharmacother,2010,44(5):863-870. 被引量:1
  • 10CITROME L.Lurasidone for schizophrenia:a review of the efficacy and safety profile for this newly approved second-generation antipsychotic[J].Int J Clin Pract,2011,65(2):189-210. 被引量:1

二级参考文献142

共引文献60

同被引文献58

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部